Surgery Partners Stock Probability of Future Stock Price Finishing Under 22.13

SGRY Stock  USD 21.01  0.09  0.43%   
Surgery Partners' future price is the expected price of Surgery Partners instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Surgery Partners performance during a given time horizon utilizing its historical volatility. Check out Surgery Partners Backtesting, Surgery Partners Valuation, Surgery Partners Correlation, Surgery Partners Hype Analysis, Surgery Partners Volatility, Surgery Partners History as well as Surgery Partners Performance.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.
  
At this time, Surgery Partners' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.12 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (320.79). Please specify Surgery Partners' target price for which you would like Surgery Partners odds to be computed.

Surgery Partners Target Price Odds to finish below 22.13

The tendency of Surgery Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 22.13  after 90 days
 21.01 90 days 22.13 
about 13.84
Based on a normal probability distribution, the odds of Surgery Partners to stay under $ 22.13  after 90 days from now is about 13.84 (This Surgery Partners probability density function shows the probability of Surgery Stock to fall within a particular range of prices over 90 days) . Probability of Surgery Partners price to stay between its current price of $ 21.01  and $ 22.13  at the end of the 90-day period is nearly 4.71 .
Given the investment horizon of 90 days Surgery Partners has a beta of 0.59. This usually implies as returns on the market go up, Surgery Partners average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Surgery Partners will be expected to be much smaller as well. Additionally Surgery Partners has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Surgery Partners Price Density   
       Price  

Predictive Modules for Surgery Partners

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Surgery Partners. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
17.6220.9524.28
Details
Intrinsic
Valuation
LowRealHigh
19.2326.8730.20
Details
13 Analysts
Consensus
LowTargetHigh
42.5746.7851.93
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.220.270.32
Details

Surgery Partners Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Surgery Partners is not an exception. The market had few large corrections towards the Surgery Partners' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Surgery Partners, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Surgery Partners within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.63
β
Beta against Dow Jones0.59
σ
Overall volatility
4.58
Ir
Information ratio -0.2

Surgery Partners Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Surgery Partners for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Surgery Partners can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Surgery Partners generated a negative expected return over the last 90 days
Surgery Partners has high historical volatility and very poor performance
The company reported the previous year's revenue of 2.74 B. Net Loss for the year was (11.9 M) with profit before overhead, payroll, taxes, and interest of 574.9 M.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Evans Jason Eric of 16500 shares of Surgery Partners at 11.54 subject to Rule 16b-3

Surgery Partners Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Surgery Stock often depends not only on the future outlook of the current and potential Surgery Partners' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Surgery Partners' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding125.6 M
Cash And Short Term Investments195.9 M

Surgery Partners Technical Analysis

Surgery Partners' future price can be derived by breaking down and analyzing its technical indicators over time. Surgery Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Surgery Partners. In general, you should focus on analyzing Surgery Stock price patterns and their correlations with different microeconomic environments and drivers.

Surgery Partners Predictive Forecast Models

Surgery Partners' time-series forecasting models is one of many Surgery Partners' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Surgery Partners' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Surgery Partners

Checking the ongoing alerts about Surgery Partners for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Surgery Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Surgery Partners generated a negative expected return over the last 90 days
Surgery Partners has high historical volatility and very poor performance
The company reported the previous year's revenue of 2.74 B. Net Loss for the year was (11.9 M) with profit before overhead, payroll, taxes, and interest of 574.9 M.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Evans Jason Eric of 16500 shares of Surgery Partners at 11.54 subject to Rule 16b-3

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.